AI
SLDB icon

Atom Investors’s Solid Biosciences SLDB Stock Holding History

Atom Investors’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$272K Buy
+27,182
New +$206K 0.02% 701
2025
Q2 		– Sell
-40,987
Closed -$152K – 770
2025
Q1 		$152K Buy
+40,987
New +$175K 0.02% 412
2024
Q3 		– Sell
-46,584
Closed -$264K – 590
2024
Q2 		$264K Sell
46,584
-54,925
-54% -$492K 0.03% 393
2024
Q1 		$1.35M Buy
+101,509
New +$950K 0.17% 187

Other funds holding SLDB

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Atom Investors's SLDB Position: Q2 2026 in Review

Atom Investors opened a new position in Solid Biosciences (SLDB) in Q2 2026: 27,182 shares worth $272K. The stake represents 0.02% of the portfolio and ranks #701 among its holdings. This is a return to the name: Atom Investors previously reported a position in SLDB as recently as Q1 2025.

Atom Investors first reported a position in SLDB in Q1 2024 and has held it in 4 quarters since. The position peaked at $1.35M in Q1 2024. 157 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.

  • Atom Investors held 27,182 shares of Solid Biosciences worth $272K as of Q2 2026.
  • Solid Biosciences was a new Atom Investors position in Q2 2026.
  • Solid Biosciences made up 0.02% of Atom Investors's portfolio in Q2 2026, its #701 holding.
  • Atom Investors first reported a position in Solid Biosciences in Q1 2024 and has held it in 4 quarters since.
  • Atom Investors's Solid Biosciences position peaked at $1.35M in Q1 2024.
  • 157 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.

Based on Atom Investors's 13F filing for Q2 2026, filed 14 Aug 2026.